Colgate-Palmolive (CL): Examining Valuation as Shares Slip Despite Stable Growth

If you have been tracking Colgate-Palmolive (CL), recent price movements might have you wondering what is really driving investor sentiment. With shares closing near $86, the stock has slipped about 5% so far this year, and nearly 15% over the past twelve months. There is no single headline causing the shift, which can be just as intriguing, especially if you are considering whether the market is sending a signal or just repricing expectations for this household products giant. Colgate-Palmolive remains a steady name in consumer staples, but the trend lately has seen momentum fade. Its three-year total return is still up 14%, and revenue as well as net income have kept growing at a mid-single digit pace, but that has not insulated the stock from the recent downturn. The company has not seen any major shakeups or bold strategic pivots, which serves as a reminder of how sentiment sometimes turns quietly, even as the business itself keeps ticking along. So with the dip in share price this year, investors must ask whether this sets up a real buying opportunity for a stable blue-chip, or if the market is simply factoring in more modest growth ahead.

Most Popular Narrative: 9.5% Undervalued

According to community narrative, Colgate-Palmolive is currently undervalued by nearly 10% relative to its estimated fair value. This estimate is based on detailed assumptions around future earnings growth, profit margins, and broader market trends.

Expansion and premiumization of core oral care lines like Colgate Total, along with the roll-out of complementary products across 75 markets, are expected to capture increased value from emerging middle-class consumers and rising health and hygiene awareness globally. These factors support top-line organic sales acceleration and improved pricing power.

Is Colgate-Palmolive's next move a game-changer? The analyst consensus narrative suggests there are growth levers that may not be immediately obvious. The valuation references bold forecasts, profit margins gradually increasing, and a future multiple typically associated with market leaders. Are you interested in the exact assumptions driving this fair value? The key drivers behind this double-digit discount could be surprising.

Result: Fair Value of $95.06 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, persistent cost pressures and slower consumer demand in key markets could challenge margin improvements and put pressure on Colgate-Palmolive's optimistic outlook.

Find out about the key risks to this Colgate-Palmolive narrative.

Another View: Discounted Cash Flow Model

Taking a different approach, our DCF model also suggests Colgate-Palmolive is trading below its estimated fair value. This reinforces the idea that the market could be undervaluing its future cash flows. Does this support your own outlook or raise new questions about the business?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Colgate-Palmolive for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Colgate-Palmolive Narrative

If you see things differently or want to take a hands-on approach, you can quickly dig into the numbers and create your own perspective in under three minutes. So why not do it your way?

A great starting point for your Colgate-Palmolive research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.

Looking for More Compelling Investment Ideas?

Don’t limit your portfolio to just one opportunity, especially when unique investment themes are gaining momentum across the market. Take the lead and capture tomorrow’s winners by searching beyond the obvious. Here are some powerful ways to spot stocks with exceptional potential right now:

• Unlock income and growth by checking out high-yield picks through dividend stocks with yields > 3%, where companies offer stable returns with dividends above 3%.
• Tap into the future of medicine and AI advances by investigating healthcare AI stocks, revealing the most promising healthcare technology innovators transforming patient care.
• Supercharge your portfolio by targeting strong balance sheets among penny stocks with strong financials, featuring smaller companies built on solid financials and long-term potential.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com